PB2171: THE NOVEL CSN5/JAB1 INHIBITOR CSN5I-3 SUPPRESSES CELL GROWTH AND UPREGULATES GENE EXPRESSION OF TYPE-I INTERFERONS (IFN) IN ANAPLASTIC LARGE CELL LYMPHOMA (ALCL)

por Xagoraris, I., Kokaraki, G., Stathopoulou, K., Claret, F. X., Drakos, E., Rassidakis, G. Z.
Publicado 2022

Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21...

por Drakos, E, Singh, R R, Rassidakis, G Z, Schlette, E, Li, J, Claret, F X, Ford, R J, Vega, F, Medeiros, L J
Publicado 2011

A four-methylated mRNA signature-based risk score system predicts survival in patients with hepatocellular carcinoma

por Wang, Yu, Ruan, Zhiping, Yu, Sizhe, Tian, Tao, Liang, Xuan, Jing, Li, Li, Wenyuan, Wang, Xiao, Xiang, LCL, Claret, F.X., Nan, Kejun, Guo, Hui
Publicado 2019